These findings uncovered the underlying mechanism of Alisol B via regulating RARα-PPARγ-CD36 cascade to alleviate NASH and highlighted Alisol B’s promising potential for the treatment of NASH. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatohepatitis.